Sana Biotechnology's allogeneic HIP technology achieved a first in T1D, showing insulin production and without ...

What Happened: SACHS's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, involves purchasing 5,000 shares of Vertex Pharmaceuticals. The total ...

The stock market indexes had big weekly gains despite some daily swings. Palantir and Shopify were among huge earnings movers.

Even with the S&P 500 near an all-time high, there are plenty of compelling growth, dividend, and value stocks to buy now.

WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) reported a return to profitability in the second quarter, driven by the termination of a regional licensing deal and renewed strategic ...

The RMR Group (Nasdaq: RMR) today announced on behalf of its managed joint venture that it has facilitated a $1.0 billion ...

The postoperative pain management market is witnessing steady growth, driven by the rising number of surgical procedures globally and increasing awar ...

Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.

Profits made by giants like Mc.Donalds and Walt Disney along with a a parade of stronger-than-expected profit reports from US ...

Gain insights into Lexicon Pharmaceuticals' Q2 2025 earnings call including R&D progress, cost savings, partnership updates, and a shift to net profitability.

Vertex Pharmaceuticals nosedived on Tuesday to hit a new all-time low following the termination of a clinical trial for an ...

September S&P 500 E-Mini futures (ESU25) are trending up +0.24% this morning as investors digested U.S. President Donald ...